Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Minden › NPI 1891873337
Hospital

CLHG - Minden, LLC

CLHG - Minden, LLC was paid $7.12M by Medicaid between Jan 2018 and Dec 2024, across 170 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.

33Billing provider infoCLHG - MINDEN, LLC
MINDEN, LA 71055
33aNPI1891873337assigned 11/01/2006
33bProvider typeRural Acute Care Hospital
28Total paid$7.12M
24GClaims345,721
24DCodes billed170
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in Louisiana

Rank by total paid#7 of 8
Median peer was paid$12.38M
This provider vs. median0.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201851,181$1.06M
201946,733$825K
202030,885$569K
202144,117$1.09M
202260,916$1.43M
202365,897$1.32M
2024incomplete45,992$821K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 24% 25,251 22,805 $1.74M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 22% 30,569 28,045 $1.54M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.3% 4,733 4,192 $379K
71046 Radiologic examination, chest; 2 views 3.8% 5,421 4,979 $270K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3.7% 2,597 2,371 $261K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.1% 40,112 35,110 $222K
80053 Comprehensive metabolic panel 2.9% 28,828 24,986 $205K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.7% 2,844 2,680 $191K
70450 Computed tomography, head or brain; without contrast material 2.4% 1,319 1,170 $169K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.3% 3,953 3,718 $167K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.2% 6,690 5,998 $154K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.1% 473 421 $151K
158 more codes
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.5% 3,188 $106K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.4% 4,765 $98K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.3% 2,915 $95K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.0% 7,045 $74K
84443 Thyroid stimulating hormone (TSH) <1% 4,989 $71K
36415 Collection of venous blood by venipuncture <1% 26,784 $67K
G0378 Hospital observation service, per hour <1% 481 $53K
71045 Radiologic examination, chest; single view <1% 2,125 $50K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,091 $48K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,434 $45K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 97 $36K
96375 Therapeutic injection; each additional sequential IV push <1% 2,893 $33K
84484 <1% 4,597 $29K
81025 <1% 5,125 $28K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,346 $28K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 364 $28K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,305 $28K
96361 Intravenous infusion, hydration; each additional hour <1% 2,247 $26K
59025 Fetal non-stress test <1% 771 $25K
86850 <1% 2,430 $25K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 383 $25K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,581 $23K
83655 <1% 1,837 $22K
80061 Lipid panel <1% 1,903 $21K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,652 $21K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 645 $19K
83036 Hemoglobin; glycosylated (A1C) <1% 2,735 $19K
86710 <1% 1,524 $19K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 589 $19K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 642 $18K
81001 <1% 8,234 $18K
86803 <1% 1,338 $17K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,033 $17K
83970 <1% 784 $16K
87340 <1% 1,631 $16K
86593 <1% 3,870 $16K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 133 $16K
84439 <1% 1,800 $15K
83690 <1% 2,827 $14K
76830 Ultrasound, transvaginal <1% 273 $14K
80069 <1% 2,351 $13K
80050 General health panel <1% 320 $13K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 322 $12K
81003 <1% 7,467 $12K
87081 <1% 1,880 $11K
83001 <1% 632 $11K
84146 <1% 548 $10K
C9399 Unclassified drugs or biologicals <1% 10,175 $10K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 265 $9K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 372 $9K
86762 <1% 636 $9K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 572 $8K
83880 <1% 431 $8K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 109 $7K
83735 <1% 1,799 $6K
82951 <1% 560 $6K
86140 <1% 1,639 $6K
84702 <1% 468 $6K
83020 <1% 458 $6K
85379 <1% 975 $6K
83605 <1% 885 $5K
82043 <1% 1,531 $5K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 863 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,677 $5K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,596 $5K
86787 <1% 410 $5K
87070 <1% 516 $5K
86703 <1% 434 $5K
82652 <1% 512 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 67 $4K
82570 <1% 1,190 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 762 $4K
0011A <1% 295 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,522 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 61 $4K
84144 <1% 191 $3K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 12 $3K
J0780 Injection, prochlorperazine, up to 10 mg <1% 593 $3K
0012A <1% 184 $3K
82947 <1% 667 $3K
72125 Computed tomography, cervical spine; without contrast material <1% 16 $3K
83002 <1% 146 $3K
82105 <1% 134 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 632 $2K
84156 <1% 740 $2K
87040 <1% 378 $2K
86696 <1% 116 $2K
76801 <1% 26 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 12 $2K
83721 <1% 306 $2K
86901 <1% 549 $2K
87807 <1% 92 $1K
0001A <1% 36 $1K
0002A <1% 37 $1K
80178 <1% 274 $1K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 294 $1K
82607 <1% 93 $1K
82746 <1% 92 $1K
73630 <1% 32 $1K
G0379 Direct admission of patient for hospital observation care <1% 20 $1K
86900 <1% 318 $963.84
82728 <1% 75 $922.56
36416 <1% 612 $894.80
85018 <1% 407 $870.40
82550 <1% 199 $857.35
96376 <1% 122 $844.65
87634 <1% 12 $844.50
82962 <1% 361 $816.41
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 66 $769.36
80048 Basic metabolic panel (calcium, ionized) <1% 106 $729.51
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 16 $640.50
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 14 $618.00
83550 <1% 73 $595.88
87428 <1% 32 $538.47
84100 <1% 189 $494.24
73610 <1% 12 $430.76
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 530 $424.54
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,765 $353.84
83540 <1% 72 $347.60
86695 <1% 35 $343.72
73560 <1% 12 $332.64
86592 <1% 52 $304.25
76775 <1% 13 $293.96
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 101 $290.67
73564 <1% 17 $271.24
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 94 $250.60
J2704 Injection, propofol, 10 mg <1% 3,835 $199.51
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 68 $189.46
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 223 $183.74
82150 <1% 34 $148.59
84134 <1% 32 $143.29
82552 <1% 15 $120.77
J2270 Injection, morphine sulfate, up to 10 mg <1% 87 $116.83
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,722 $115.40
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 110 $109.67
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 62 $90.74
82310 <1% 60 $72.64
81000 <1% 37 $72.03
J3010 Injection, fentanyl citrate, 0.1 mg <1% 879 $57.62
85652 <1% 33 $56.82
85045 <1% 12 $53.84
J3490 Unclassified drugs <1% 15 $52.44
J7510 Prednisolone oral, per 5 mg <1% 442 $50.62
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 18 $45.86
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 89 $44.63
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 877 $26.32
J2060 Injection, lorazepam, 2 mg <1% 14 $25.99
J1170 Injection, hydromorphone, up to 4 mg <1% 50 $25.92
85730 <1% 37 $24.10
85610 <1% 50 $21.49
91301 <1% 305 $1.60
A9270 Non-covered item or service 0% 883 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 40 $0.00
73502 0% 12 $0.00
91300 0% 81 $0.00
87631 0% 68 $0.00
85014 0% 38 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 20 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPEARSON, GREGORY (CEO/ADMINISTRATOR)